Status:
COMPLETED
Effect of the Alpha-galacto-oligasaccharides on Weight Loss in Overweight or Moderately Obeses Adults : A Randomized Controlled Double Blinded Trial Versus Placebo
Lead Sponsor:
Olygose
Collaborating Sponsors:
Institute of Cardiometabolism and Nutrition, France
Conditions:
Randomized Versus Placebo
Controlled
Eligibility:
All Genders
20-70 years
Phase:
NA
Brief Summary
Clinical intervention on overweight or moderately obeses adults. The objective of this trial is to demonstrate the superior eficacy of Alphagos to placebo on weight loss during a low-calorie diet of 1...
Eligibility Criteria
Inclusion
- Body Mass Index \> or equal 25 and \< 35
- Use of effective contraception in women of childbearing age
Exclusion
- Pregnant women (positive pregnancy test) or breastfeeding
- Anti-hypertensive or cholesterol treatment
- HIV infection or HCV
- Hepatic and/or severe renal failure
- Heart attack within 6 months prior the selection
- Heart failure known
- Inflammatory disease known
- Cancer or have had cancer within 3 years prior to the study except for basal cell skin cancers
- Diabetes defined by blood glucose greater than or equal to 1.26 g/L
- Gastrointestinal disease known
- Bariatric surgery
Key Trial Info
Start Date :
September 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2014
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02228746
Start Date
September 1 2013
End Date
August 1 2014
Last Update
August 29 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre d'Investigation Clinique Paris-Est/ Bâtiment Antonin Gosset Hôpital de la Pitié Salpêtrière- 56 Boulevard Vincent Auriol
Paris, France, 75013